Ovrom Erik A, Mostert Karson A, Khakhkhar Shivani, McKee Daniel P, Yang Padao, Her Yeng F
Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.
Department of Physical Medicine and Rehabilitation, Mayo Clinic Hospital, Rochester, MN 55905, USA.
Biomedicines. 2023 Apr 7;11(4):1119. doi: 10.3390/biomedicines11041119.
This narrative review summarizes the current knowledge of the genetic and epigenetic contributions to the development of fibromyalgia (FM). Although there is no single gene that results in the development of FM, this study reveals that certain polymorphisms in genes involved in the catecholaminergic pathway, the serotonergic pathway, pain processing, oxidative stress, and inflammation may influence susceptibility to FM and the severity of its symptoms. Furthermore, epigenetic changes at the DNA level may lead to the development of FM. Likewise, microRNAs may impact the expression of certain proteins that lead to the worsening of FM-associated symptoms.
本叙述性综述总结了目前关于遗传和表观遗传对纤维肌痛(FM)发展影响的知识。虽然没有单一基因会导致FM的发生,但本研究表明,参与儿茶酚胺能途径、5-羟色胺能途径、疼痛处理、氧化应激和炎症的基因中的某些多态性可能会影响FM的易感性及其症状的严重程度。此外,DNA水平的表观遗传变化可能导致FM的发生。同样,微小RNA可能会影响某些导致FM相关症状恶化的蛋白质的表达。